XTANT MEDICAL HOLDINGS, INC. (XTNT)

0.38 +15.15% (+0.05)

Over 6M: -33.3%

2026-08-28
0.3 0.4 0.5 0.6
Mar Apr May Jun Jul Aug

Financials Quarterly

Q3 '21 — Revenue: 13.8M Q3 '21 — Operating Cash Flow: -926K Q3 '21 — Free Cash Flow: -1.3M Q3 '21 — Net Income: -1.8M Q4 '21 — Revenue: 14M Q4 '21 — Operating Cash Flow: 423K Q4 '21 — Free Cash Flow: -203K Q4 '21 — Net Income: -2.3M Q1 '22 — Revenue: 13M Q1 '22 — Operating Cash Flow: -1M Q1 '22 — Free Cash Flow: -1.5M Q1 '22 — Net Income: -2.2M Q2 '22 — Revenue: 15.3M Q2 '22 — Operating Cash Flow: 15K Q2 '22 — Free Cash Flow: -311K Q2 '22 — Net Income: -1.7M Q3 '22 — Revenue: 14.5M Q3 '22 — Operating Cash Flow: -2.1M Q3 '22 — Free Cash Flow: -2.6M Q3 '22 — Net Income: -2.4M Q4 '22 — Revenue: 15.3M Q4 '22 — Operating Cash Flow: -2.3M Q4 '22 — Free Cash Flow: -2.7M Q4 '22 — Net Income: -2.2M Q1 '23 — Revenue: 17.9M Q1 '23 — Operating Cash Flow: -2.2M Q1 '23 — Free Cash Flow: -2.7M Q1 '23 — Net Income: -2.1M Q2 '23 — Revenue: 20.2M Q2 '23 — Operating Cash Flow: -2.5M Q2 '23 — Free Cash Flow: -2.9M Q2 '23 — Net Income: -2.2M Q3 '23 — Revenue: 25M Q3 '23 — Operating Cash Flow: -3.8M Q3 '23 — Free Cash Flow: -4.1M Q3 '23 — Net Income: 9.2M Q4 '23 — Revenue: 28.1M Q4 '23 — Operating Cash Flow: -915K Q4 '23 — Free Cash Flow: -1.3M Q4 '23 — Net Income: -4.3M Q1 '24 — Revenue: 27.9M Q1 '24 — Operating Cash Flow: -5.8M Q1 '24 — Free Cash Flow: -6.5M Q1 '24 — Net Income: -4.4M Q2 '24 — Revenue: 29.9M Q2 '24 — Operating Cash Flow: -5.1M Q2 '24 — Free Cash Flow: -5.7M Q2 '24 — Net Income: -3.9M Q3 '24 — Revenue: 27.9M Q3 '24 — Operating Cash Flow: -1.7M Q3 '24 — Free Cash Flow: -3.8M Q3 '24 — Net Income: -5M Q4 '24 — Revenue: 31.5M Q4 '24 — Operating Cash Flow: 665K Q4 '24 — Free Cash Flow: -7K Q4 '24 — Net Income: -3.2M Q1 '25 — Revenue: 32.9M Q1 '25 — Operating Cash Flow: 1.3M Q1 '25 — Free Cash Flow: 87K Q1 '25 — Net Income: 58K Q2 '25 — Revenue: 35.4M Q2 '25 — Operating Cash Flow: 1.3M Q2 '25 — Free Cash Flow: 910K Q2 '25 — Net Income: 3.5M Q3 '25 — Revenue: 33.3M Q3 '25 — Operating Cash Flow: 4.6M Q3 '25 — Free Cash Flow: 4.2M Q3 '25 — Net Income: 1.3M Q4 '25 — Revenue: 32.4M Q4 '25 — Operating Cash Flow: 5.4M Q4 '25 — Free Cash Flow: 5M Q4 '25 — Net Income: 57K Q1 '26 — Revenue: 20.9M Q1 '26 — Operating Cash Flow: -2.1M Q1 '26 — Free Cash Flow: -2.3M Q1 '26 — Net Income: -3.1M Q2 '26 — Revenue: 23M Q2 '26 — Operating Cash Flow: -7.3M Q2 '26 — Free Cash Flow: -7.6M Q2 '26 — Net Income: -9.4M -9M 0 9M 18M 27M 36M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.6
ROIC 14.0%
OE margin -3.3%
Accruals -14.7%
Gross margin 59.4%
ROCE 14.7%
FCF margin -0.64%
OCF / EBIT 0.078×
OCF margin 0.52%
Profit margin -10.2%
ROA -14.0%
ROE -27.8%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.5
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.2
ND/EBITDA —
F-score 8.0 pts
Net debt / Eq 0.029×
Cash / Debt 0.89×
Debt / Eq 0.28×
Quick ratio 1.1×
Cash runway —
Debt payback —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.7
Sales CAGR 4Y +24.8%
Sales/sh Y/Y -23.6%
Sales Q/Q -35.0%
Shares change +12.3%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.